Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001562180-22-000750

Options or other derivatives

  • Chief Scientific Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bellon Steven F. Chief Scientific Officer 2022-01-26 Grant or award · Stock Option (right to buy) +150,000 150,000 D
Loading xslF345X03/primarydocument.xml…